LD-2 disclosure · 4th Quarter - Termination
AVANIR PHARMACEUTICALS
Expenses$40Kself-filed spend
Client
- Location
- California · United States of America
Registrant
- Description
- ​Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales
- Location
- Aliso Viejo, California, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 19, S. 2164, Lower Costs, More Cures Act of 2021. H.R. 5376, Build Back Better Act, specifically issues dealing with Medicare.
LobbyistsCATHERINE DRATZ FERGUSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R.7667 - Food and Drug Amendments of 2022, specifically provisions regarding the Prescription Drug User Fee Act (PDUFA). H.R.5376 - Inflation Reduction Act of 2022, specifically provisions relating to prescription drug pricing. Issues related to mental health.
LobbyistsCATHERINE DRATZ FERGUSON
TargetedSENATE · HOUSE OF REPRESENTATIVES